Omega Therapeutics (OMGA)
(Delayed Data from NSDQ)
$1.85 USD
+0.06 (3.35%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $1.87 +0.02 (1.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Omega Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -97.43 | -102.70 | -68.28 | -29.45 | NA |
Depreciation/Amortization & Depletion | 6.82 | 5.26 | 1.48 | 1.19 | NA |
Net Change from Assets/Liabilities | -9.37 | -9.88 | 4.51 | 1.46 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 8.46 | 8.81 | 4.69 | 0.66 | NA |
Net Cash From Operating Activities | -91.51 | -98.52 | -57.61 | -26.13 | NA |
Property & Equipment | -2.22 | -1.38 | -1.47 | -1.81 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 49.73 | -16.68 | -38.93 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 47.52 | -18.06 | -40.40 | -1.81 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 40.49 | 0.71 | 253.75 | 48.62 | NA |
Issuance (Repayment) of Debt | -1.00 | 0.00 | 8.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 2.34 | 0.00 | -0.22 | 0.00 | NA |
Net Cash from Financing Activities | 41.82 | 0.71 | 261.54 | 48.62 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -2.17 | -115.87 | 163.53 | 20.68 | NA |
Cash at Beginning of Period | 70.96 | 186.82 | 23.29 | 2.62 | NA |
Cash at End of Period | 68.78 | 70.96 | 186.82 | 23.29 | NA |
Diluted Net EPS | -1.80 | -2.14 | -3.05 | NA | NA |
Fiscal Year End for Omega Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -20.13 | -97.43 | -77.21 | -54.97 |
Depreciation/Amortization & Depletion | NA | 1.83 | 6.82 | 5.02 | 3.15 |
Net Change from Assets/Liabilities | NA | 3.07 | -9.37 | -8.56 | -3.61 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 3.43 | 8.46 | 6.33 | 4.04 |
Net Cash From Operating Activities | NA | -11.81 | -91.51 | -74.42 | -51.38 |
Property & Equipment | NA | -0.54 | -2.22 | -1.76 | -1.03 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 5.00 | 49.73 | 47.13 | 47.13 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 4.47 | 47.52 | 45.38 | 46.10 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.02 | 40.49 | 40.49 | 40.48 |
Issuance (Repayment) of Debt | NA | -1.09 | -1.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 2.34 | -0.29 | -0.27 |
Net Cash from Financing Activities | NA | -1.07 | 41.82 | 40.20 | 40.21 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -8.41 | -2.17 | 11.15 | 34.92 |
Cash at Beginning of Period | NA | 68.78 | 70.96 | 70.96 | 70.96 |
Cash at End of Period | NA | 60.37 | 68.78 | 82.11 | 105.88 |
Diluted Net EPS | NA | -0.36 | -0.36 | -0.40 | -0.54 |